A detailed history of Aaron Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aaron Wealth Advisors LLC holds 10,068 shares of ABBV stock, worth $2.02 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
10,068
Previous 9,422 6.86%
Holding current value
$2.02 Million
Previous $1.62 Million 23.02%
% of portfolio
0.24%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $105,840 - $128,767
646 Added 6.86%
10,068 $1.99 Million
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $16,407 - $19,160
106 Added 1.14%
9,422 $1.62 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $440,463 - $501,867
2,756 Added 42.01%
9,316 $1.7 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $2.79 Million - $3.15 Million
-20,310 Reduced 75.59%
6,560 $1.02 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $54,905 - $63,561
411 Added 1.55%
26,870 $4.01 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $28,489 - $35,453
-215 Reduced 0.81%
26,459 $3.56 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $80,547 - $92,762
557 Added 2.13%
26,674 $4.25 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $327,933 - $393,277
2,371 Added 9.98%
26,117 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $2.67 Million - $3.06 Million
19,882 Added 514.54%
23,746 $3.19 Million
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $37.6 Million - $47.8 Million
-273,019 Reduced 98.6%
3,864 $591,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $36.3 Million - $45.1 Million
275,176 Added 16120.45%
276,883 $1.71 Million
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $183,383 - $232,032
1,707 New
1,707 $231,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aaron Wealth Advisors LLC Portfolio

Follow Aaron Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aaron Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aaron Wealth Advisors LLC with notifications on news.